These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23019811)

  • 1. Two unusual cases of Graves' hyperthyroidism with unilaterally increased 99mTc uptake.
    Decallonne B; Vanderstappen H; Thijs M
    Acta Clin Belg; 2012; 67(4):306-7. PubMed ID: 23019811
    [No Abstract]   [Full Text] [Related]  

  • 2. Is thyroid scintigraphy necessary before I-131 therapy for hyperthyroidism? Concise communication.
    Ripley SD; Freitas JE; Nagle CE
    J Nucl Med; 1984 Jun; 25(6):664-7. PubMed ID: 6327946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroid gland hemiagenesis with Graves' disease].
    Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
    Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthyroidism with or without pyramidal lobe Graves' disease or disseminated autonomously functioning thyroid tissue?
    Wahl R; Müh U; Kallee E
    Clin Nucl Med; 1997 Jul; 22(7):451-8. PubMed ID: 9227866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' disease with unilateral radioisotope uptake.
    Gratz S; Barth P; Arnold R; Behr TM
    Nuklearmedizin; 2004 Oct; 43(5):N66-8. PubMed ID: 15536692
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo determination of thyroid iodine content in functional autonomy].
    Leisner B
    Acta Med Austriaca; 1990; 17 Suppl 1():33-5. PubMed ID: 2117838
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of thyroid scanning in hyperthyroidism.
    Fogelman I; Cooke SG; Maisey MN
    Eur J Nucl Med; 1986; 11(10):397-400. PubMed ID: 3009197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover.
    de Jong JA; Verkooijen HM; Valk GD; Zelissen PM; de Keizer B
    Clin Nucl Med; 2013 Jun; 38(6):401-6. PubMed ID: 23579983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthyroidism: an underappreciated cause of diffuse bone disease.
    Swislocki AL; Barnett CA; Darnell P; Noth RH
    Clin Nucl Med; 1998 Apr; 23(4):241-3. PubMed ID: 9554201
    [No Abstract]   [Full Text] [Related]  

  • 10. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
    Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
    J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia due to Graves' disease in a patient with thyroid hemiagenesis.
    Kebapçilar L; Akinci B; Demir T; Bayraktar F; Yeşil S
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(3):159-62. PubMed ID: 19857196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.
    Ikekubo K; Hino M; Ito H; Koh T; Ishihara T; Kurahachi H; Kasagi K; Hidaka A; Mori T
    Ann Nucl Med; 1990 Jul; 4(2):43-8. PubMed ID: 2171608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A singular case of Graves' disease in congenital thyroid hemiagenesis.
    Baldini M; Orsatti A; Cantalamessa L
    Horm Res; 2005; 63(3):107-10. PubMed ID: 15775712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism.
    Giovanella L; Ceriani L; Ghelfo A
    Horm Metab Res; 2008 Jul; 40(7):484-6. PubMed ID: 18393171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quick diagnosis of hyperthyroidism with semiquantitative 30-minute technetium-99m-methoxy-isobutyl-isonitrile thyroid uptake.
    Kao CH; Wang SJ; Liao SQ; Lin WY; Hsu CY
    J Nucl Med; 1993 Jan; 34(1):71-4. PubMed ID: 8418274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid gland hemiagenesis with Graves' disease.
    Zangeneh F; Miller JL; Intenzo CM
    Thyroid; 2001 Jun; 11(6):603. PubMed ID: 11442010
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' disease. Initial presentation with exophthalmos and solitary hot nodule.
    Vento JA; Slavin JD; Reardon GE; Spencer RP
    Clin Nucl Med; 1986 Jun; 11(6):404-6. PubMed ID: 3013482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.